Invega Trinza® (paliperidone palmitate)
for Schizophrenia

Invega Trinza (paliperidone palmitate) is an atypical antipsychotic given once every 3 months to treat schizophrenia. Invega Trinza is an extended-release form that maintains stable drug levels, overcoming fluctuations seen with immediate-release versions. It helps regulate brain chemicals, dopamine and serotonin, which are believed to be imbalanced in schizophrenia.

Heart